Literature DB >> 17344014

High-performance liquid chromatographic method for the determination and pharmacokinetic study of oxypeucedanin hydrate and byak-angelicin after oral administration of Angelica dahurica extracts in mongrel dog plasma.

Ying Xie1, Yi Chen, Mei Lin, Jun Wen, Guorong Fan, Yutian Wu.   

Abstract

A high-performance liquid chromatographic method was developed and validated for the determination and pharmacokinetic study of oxypeucedanin hydrate and byak-angelicin after oral administration of Angelica dahurica extracts in mongrel dog plasma. The coumarin components and the internal standard isopsoralen were extracted from plasma samples with the mixture of tert-butyl methyl ether and n-hexane (4:1, v/v). Chromatographic separation was performed on a C(18) column (200 mm x 4.6mm, 5 microm) with the mobile phase acetonitrile-methanol-water-acetic acid (20:15:65:2, v/v/v/v) at a flow-rate of 1.0 ml/min. Only the peak of oxypeucedanin hydrate and byak-angelicin could be detected in dog plasma after oral administration of ethanol extracts of A. dahurica mainly containing xanthotoxol, osthenol, imperatorin, oxypeucedanin hydrate and byak-angelicin. The calibration curves of oxypeucedanin hydrate and byak-angelicin were linear over a range of 22.08-8830.00 and 6.08-2430.00 ng/ml in dog plasma, respectively. The quantification limit of oxypeucedanin hydrate and byak-angelicin in dog plasma was 22.08 and 6.08 ng/ml, respectively. The intra- and inter-day precision was less than 7.6% and 8.5% and the accuracy was from 91.9% to 106.1%. The lowest absolute recoveries of oxypeucedanin hydrate and byak-angelicin were 85.7% and 87.0%, respectively. The method was successfully applied to the pharmacokinetic studies of oxypeucedanin hydrate and byak-angelicin in dog plasma after oral administration of ethanol extracts from A. dahurica.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17344014     DOI: 10.1016/j.jpba.2007.02.002

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  3 in total

1.  Byakangelicin induces cytochrome P450 3A4 expression via transactivation of pregnane X receptors in human hepatocytes.

Authors:  Jian Yang; Xiaofei Luan; Haiyan Gui; Peng Yan; Dongfang Yang; Xiulong Song; Wei Liu; Gang Hu; Bingfang Yan
Journal:  Br J Pharmacol       Date:  2011-01       Impact factor: 8.739

2.  Association of genetic polymorphisms on BTNL2 with susceptibility to and prognosis of dilated cardiomyopathy in a Chinese population.

Authors:  Liang Cheng; Rong Zhao; ZhenXiao Jin; Kai Ren; Chao Deng; Shiqiang Yu
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

Review 3.  The Angelica dahurica: A Review of Traditional Uses, Phytochemistry and Pharmacology.

Authors:  Hui Zhao; Ya-Long Feng; Ming Wang; Jing-Jing Wang; Tian Liu; Jun Yu
Journal:  Front Pharmacol       Date:  2022-07-01       Impact factor: 5.988

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.